Fanfei Meng was staring at a problem that has quietly plagued gene therapy for years: the medicine arrives at the cell, but never gets inside. At the University of Houston’s College of Pharmacy, Meng and his team have cracked part of the code with a solution so simple it borders on elegant—salt. By loading lipid nanoparticles (LNPs) with salt, they’ve found a way to dramatically improve the delivery of mRNA and other genetic therapeutics into the cytosol, the inner chamber of the cell where these treatments must act to be effective. The discovery, published in the journal Small, could reshape how scientists design next-generation gene medicines.
For all the promise of mRNA vaccines and gene-editing tools like CRISPR, one stubborn hurdle has remained: endosomal entrapment. Once LNPs enter a cell, they’re often swallowed by endosomes—tiny cellular bubbles that act like sealed rooms, trapping the therapeutic cargo before it can do its job. Up to 99% of genetic material can be lost this way, rendering even the most advanced therapies ineffective. Meng’s breakthrough lies in exploiting a basic law of physics: osmosis. When salt-loaded LNPs break down inside endosomes, the sudden influx of ions draws water in, creating internal pressure that bursts the endosome open—like a balloon popping—releasing the payload into the cytosol.
The team’s salt-loaded LNPs, tested using cryogenic transmission electron microscopy, showed significantly enhanced endosomal escape and cytosolic delivery of nucleic acids. Unlike previous approaches that required complex chemical redesigns of the nanoparticles, this method works by simply adjusting the ionic content—an innovation that’s both scalable and compatible with existing manufacturing processes. That’s critical for accelerating the development of new treatments for cancer, rare genetic diseases, and next-gen vaccines. “We are introducing salt-loaded lipid nanoparticles as a novel and broadly applicable design principle for gene delivery,” said Meng. “What makes this exciting is that we can significantly improve delivery efficiency without needing to invent entirely new materials.”
The research team includes Cao Thuy Giang Nguyen and Hoang Quan Truong from the University of Massachusetts Lowell, and Yanghao Li and Urmila Kafle from the University of Houston. Their collaborative work underscores how cross-institutional science is driving quiet revolutions in medicine. With gene-based therapies poised to expand globally, this salt-based strategy offers a practical, low-cost way to boost their potency.
As the world looks beyond the pandemic-era success of mRNA vaccines, discoveries like this remind us that sometimes, the most powerful answers come not from reinventing the wheel—but from seasoning it just right.